Kezar Life Sciences halts mid-stage lupus nephritis trial after four people die
Kezar Life Sciences Inc., a US-based biotechnology company, has stopped a trial in patients with a type of kidney disease after four people.
Drugs
Health
Pharma
Drugs
Health
Pharma
AstraZeneca acquires France’s Amolyt Pharma for $1.05 billion
British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.
Drugs
Health
Pharma
Hunger, diseases grip undernourished children, women in Gaza: WHO report
HQ Team February 20, 2024: About 16% of children or one in six children under two years of age in the Northern Gaza.
Drugs
Health
Medical
Molecular coating on X chromosomes may explain higher autoimmune susceptibility in women
Bharti Jayshankar February 2, 2024: A new study has come up with an explanation for the heightened susceptibility of women to autoimmune diseases.
Drugs
Health
Pharma
Scientists’ eye easy diagnosis for adenomyosis condition in women
Physicians and scientists are on the lookout for a new non-invasive diagnostic process for a lesser-known condition called adenomyosis in women.